Literature DB >> 6499883

Importance of laboratory clinical investigation in the diagnosis of immune vasculitis with neurological manifestation.

R Hagenah, S H Senff.   

Abstract

In this study 23 cases of immune vasculitis with predominance of neurological symptoms were analysed. Besides patient history and neurological examination, myelotomy is the most relevant means of diagnosis in immune vasculitis. For this reason myelotomy should be integrated in routine diagnostic methods if the diagnosis immune vasculitis is discussed. Other laboratory parameters have no great relevance in the diagnosis of immune vasculitis. A higher specificity of antibody tests, especially in the case of ANA, might be able to replace myelotomy in the diagnosis of immune vasculitis. The relevance of laboratory parameters in the diagnosis of immune vasculitis in neurological patients was examined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6499883     DOI: 10.1007/bf00381213

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  18 in total

1.  [The Sharp syndrome ("mixed connective tissue disease")].

Authors:  M Rosenthal
Journal:  Schweiz Med Wochenschr       Date:  1976-01-31

2.  THE BONE MARROW IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  R BURKHARDT
Journal:  Semin Hematol       Date:  1965-01       Impact factor: 3.851

3.  [Comparison studies for the detection of antinuclear factors].

Authors:  K Helmke; B Schäfer; K Federlin
Journal:  Verh Dtsch Ges Inn Med       Date:  1978

4.  [Comparative study on the detection of antinuclear antibodies with special reference to disseminated lupus erythematosus].

Authors:  H R Gemünd; D Mitrenga; K Schumacher
Journal:  Verh Dtsch Ges Inn Med       Date:  1978

Review 5.  [Histomorphological studies on the role of the bone marrow in rheumatic diseases].

Authors:  R Burkhardt
Journal:  Z Gesamte Exp Med       Date:  1967

6.  [Differentiation of antinuclear antibodies for the improvement of their diagnostic significance].

Authors:  M Rosenthal; B Stojan; W Müller
Journal:  Dtsch Med Wochenschr       Date:  1976-03-05       Impact factor: 0.628

7.  [The treatment of collagen diseases].

Authors:  A Calin
Journal:  Internist (Berl)       Date:  1980-11       Impact factor: 0.743

8.  [Neuropsychiatric manifestations in patients with systemic lupus erythematosus].

Authors:  R Hohmeister; B Bresnihan; G R Hughes
Journal:  Schweiz Med Wochenschr       Date:  1978-12-16

9.  Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.

Authors:  G C Sharp; W S Irvin; R L LaRoque; C Velez; V Daly; A D Kaiser; H R Holman
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

10.  Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients.

Authors:  P M Moore; A S Fauci
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.